Pathophysiological rationale and prospects for using xylitol in the nutritional support of cancer patients

Oncologist

Abstract. The literature review considers the prospects of using five-carbon alcohol xylitol as a sugar substitute, which is an alternative to excessive consumption of refined carbohydrates.
It was found that xylitol use leads to an increase in glucose tolerance, stabilizes the metabolic situation in patients with unstable course of diabetes mellitus. It has antiketogenic properties and provides a slow but steady energy production.
The use of xylitol in parenteral nutrition promotes an increase in the content of adenosine triphosphate and other adenine nucleotides in the liver, stimulates the protein-forming and biliary excretory function of the liver, reduces the amount of free fatty acids in the blood and the production of ketone bodies.
The ability of Хylat to inhibit Warburg effect opens up new opportunities for potential improvement in the treatment results of patients with malignant tumors.
Keywords: sugar alcohols; xylitol; Warburg effect; Хylat

24 April, 2020

Authors:

Hryvkova Larysa

Products:

Xylat®

Learn more

The anesthesiologist and specialist on medical emergency conditions

Place of modern regional anesthesia techniques in the perioperative period. Advantages of long-term epidural analgesia with ropivacaine

General practitioner

Antiseptic solution for the prevention and treatment of injuries and inflammatory processes of the skin

Cardiologist

The characteristics of preventive and therapeutic effectiveness of new domestic anti-septic medicinal product Horosten

The epidemiological situation at the end of the second millennium is characterized by a shift of etiological structure of infectious diseases towards those caused by opportunistic potentially pathogenic microorganisms.
Cardiologist

Decametoxin-based anti-septic solutions vs povidone-iodine in preventive therapy of the skin in venous catheter care

Venous catheters are the most common devices implanted to provide venous access for patients’ treatment.
Cardiologist

Efficacy and safety of iron (III)-hydroxide sucrose complex in correction of anaemia stage 5D chronic kidney disease hemodialysis patients not treated by erythropoiesis-stimulating agents (prospective analysis)

Anaemia is a characteristic feature of chronic kidney disease (CKD), especially in advanced stages of the disease, especially in patients with stage 5 treated with methods of renal substitution therapy.

Cardiologist

Possibilities of correction of iron deficiency anemia in patients with chronic kidney disease

Anemia is the earliest and the most frequent complication of chronic kidney disease (CKD)